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Abstract
Background: Cholelithiasis has become a major health problem in Taiwan. The predominant type of gallstone
found in Asian populations differs from that in the West, indicating possible differences in the etiology and risk
factors for cholelithiasis. The aim of this study is to investigate the risk factors for cholelithiasis using data
representative of the general population.
Methods: We performed a population-based, case-control study in which we analyzed medical data for 3725
patients newly diagnosed with cholelithiasis and 11175 gender- and age-matched controls with no history of
cholelithiasis, using information obtained from the 2005 Registry for Beneficiaries of the National Health Insurance
Research Database. Coexisting medical conditions were included in the analysis. Relative risks were estimated by
adjusted odds ratio (OR) and 95% confidence interval (CI) using a multivariate logistic regression analysis.
Results: After controlling for the other covariates, multivariate logistic regression analysis identified the following as
risk factors for cholelithiasis (in descending order of contribution): Among all patients - hepatitis C (OR = 2.78),
cirrhosis (OR = 2.47), hepatitis B (OR = 2.00), obesity (OR = 1.89), and hyperlipidemia (OR = 1.54); Among women -
hepatitis C (OR = 3.05), cirrhosis (OR = 1.92), obesity (OR = 1.91), menopause (OR = 1.61), hepatitis B (OR = 1.54),
and hyperlipidemia (OR = 1.49). Diabetes mellitus appeared to have a marked influence on the development of
cholelithiasis but was not identified as a significant independent risk factor for cholelithiasis.
Conclusions: The risk factors for cholelithiasis were obesity, hyperlipidemia, hepatitis B infection, hepatitis C
infection, and cirrhosis in both genders, and menopause in females. Despite differences in the predominate type of
gallstone in Asian versus Western populations, we identified no unique risk factors among the population of
Taiwan.
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Background
Cholelithiasis (the presence of one or more gallstones in
the bladder) represents a significant burden for health-
care systems worldwide [1] and is one of the most com-
mon disorders among patients presenting to emergency
rooms with abdominal discomfort–e.g., epigastric pain,
nausea, vomiting, loss of appetite [2]. Ethnicity and
family traits are recognized as contributing factor [3].
Cholelithiasis is known to affect 60-70% of Native
Americans and a proportionately smaller number indivi-
duals of mixed Hispanic/Native American background
[4]. The incidence is at least 10% among white adults in
Western countries [5], and even lower in African Amer-
icans and East Asians [4]. Risk factors associated with
cholelithiasis in the West include gender (F > M), age,
obesity, metabolic syndrome, rapid appetite loss, hepati-
tis C, cirrhosis, and high caloric intake [4,6].
Cholelithiasis is also on the rise and becoming a major
health problem in Taiwan [7,8], with some estimates
indicating an increase in prevalence from 4.3% in 1989
to as high as 10.7% in 1995 [8]. In the West, 80-90% of
gallstones are cholesterol stones [1], whereas the major-
ity of gallstones found in Asian populations are pigment
stones (high-residue pigment, low-residue pigment, and
muddy pigment types), derived largely from salts or
polymers of bilirubinate [9-11].
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strategies for the prevention and detection of chole-
lithiasis in Taiwan, it will be important to identify and
understand risk factors that may be unique in the popu-
lation. Differences in the prevalent type of gallstone
indicate a potential differences in the etiology of chole-
lithiasis in Taiwan versus the West. A small number of
studies have explored risk factors for cholelithiasis in
the Taiwanese population [8,12-15]. Chen et al. [12] stu-
died individuals from a rural village in Taiwan and
found an overall prevalence of gallstone disease of
around 5%. They identified age and fatty liver to be sig-
nificant risk factors in both sexes, with no overall link
to gender. Liu et al. [16] assessed cholelithiasis in
healthy, paid volunteers admitted to hospital and identi-
fied a prevalence of 5.3%. Cholelithiasis in this study
was linked to age, obesity (body mass index [BMI] ≥ 27
kg/m
2), and type 2 diabetes, but not gender. A few addi-
tional studies have identified diastolic blood pressure,
elevated alanine aminotransferase levels, and waist cir-
cumference as risk factors for cholelithiasis within high
risk subgroups of obese individuals [14] and patients
with type 2 diabetes [8,15].
The above studies suggest similarities as well as differ-
ences between the nature of cholelithiasis in Taiwan
and in the West. There is a selection bias associated
with each of these studies, however, due to the focus on
a particular subgroup within the Taiwanese population,
and as a result they may not offer an accurate represen-
tation of risk factors for cholelithiasis among the general
population. The aim of this study was to perform a
case-controlled analysis of medical information from the
nation-wide 2005 Registry for Beneficiaries of the
National Health Insurance Research Database. While
the use of such a database provides access to a wealth
of information on the health status of a large number of
patients, it also has limitations. For example, the data-
base did not reveal the criteria on which the diagnoses
of cholelithiasis were based. Nevertheless, our data offer
a better understanding of medical factors contributing
to the development of cholelithiasis across the general
population of Taiwan.
Methods
Study Population
We identified total of 14900 patients from a random
sample of the 2005 Registry for Beneficiaries of the
National Health Insurance Research Database. This
database contains longitudinal insurance records of
reimbursement claims for the years 2003 to 2007, which
includes the original claim data of 1000000 beneficiaries.
This insurance program has covered more than 96% of
Taiwan’s population and has contracted with 97% of
hospitals and clinics in Taiwan, since March 1995 [17].
The database included information regarding date of
birth, gender, medical diagnosis, and medical proce-
dures. These data were released for public access and
patient identities were not revealed. Information was
obtained with the authorization of Bureau of National
Health Insurance, Department of Health in Taiwan.
This study was exempt from full review by the institu-
tion review board.
Criteria and Definition
We used diagnostic guidelines from the International
Classification of Diseases (ICD) 9
th Revision [18] to
identify individuals newly diagnosed with cholelithiasis
(ICD-9-CM 574) who were 20 years of age and above in
2006-2007. Individuals meeting these criteria were
selected randomly, without regard to age or gender, for
inclusion in the case group. Because the database did
not provide the diagnostic criteria for cholelithiasis,
these patients are more appropriately designated as hav-
ing symptomatic cholelithiasis, i.e., calculus of the gall-
bladder without mention of cholecystitis. Each
individual in the case group was matched to three indi-
viduals of the same age and sex in the control group.I t
should be noted that because the control group was
constructed in this manner–i.e., by matching exactly the
age and sex of controls to individuals in the case
group–the mean ages for the two groups are identical,
as are the percentages of males and females in the two
groups. Furthermore, because of the large n values, the
standard deviations for the case and control groups are
identical to within three significant figures (see Table 1).
Controls were defined as individuals who had neither
been diagnosed with cholelithiasis nor undergone a
related medical procedure, such as cholecystectomy
(ICD-9-CM 51.22 and 51.23) or common duct explora-
tion for removal of calculus (ICD-9-CM 51.41) between
the years 2003 to 2007. The age for individuals in the
case group was defined as the age of onset of chole-
lithiasis as determined at the time of diagnosis. Age for
individuals in the control group was defined as their age
2007.
Table 1 Age and Gender Characteristics of the Study
Population
a
Symptomatic Cholelithiasis
Yes
(n = 3725)
No
(n = 11175)
Age (year) 55.9 ± 15.9 55.9 ± 15.9
Male 1621 (43.5%) 4863 (43.5%)
Female 2104 (56.5%) 6312 (56.5%)
a The average ages and gender percentages for the case and control groups
are identical, because individuals in the control group were age- and gender-
matched to individuals in the case group.
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factors for cholelithiasis were obesity (ICD-9-CM 278.00
and 278.01), diabetes mellitus (ICD-9-CM 250), hyperli-
pidemia (ICD-9-CM 272.0, 272.1, 272.2, 272.3 and
272.4), chronic kidney disease (ICD-9-CM 585, 586,
588.8 and 588.9), hepatitis B infection (ICD-9-CM
V02.61, 070.20, 070.22, 070.30 and 070.32), hepatitis C
infection (ICD-9-CM V02.62, 070.41, 070.44, 070.51 and
070.54), cirrhosis (ICD-9-CM 571.2, 571.5 and 571.6),
and menopause (ICD-9-CM V49.81, 627.2, 627.8 and
627.9). Only a relatively small percentage of individuals,
those presenting with acute cholecystitis, would nor-
mally undergo emergency cholecystectomy at first pre-
sentation. Therefore, we elected to included in this
study only individuals who had presented and been
diagnosed with cholelithiasis in ambulatory care twice
during the period from 2003 to 2005.
Statistical analysis
Data are presented as the mean ± standard deviation (SD)
of n determinations; gender was presented as counts with
percentages. The associations between potential medical
risk factors and cholelithiasis were summarized as odds
ratios (OR) with the 95% confidence interval (CI) in the
univariate conditional logistic regression models. To inves-
tigate the risk factors for cholelithiasis while controlling for
the other covariates, those medical conditions meeting the
statistical criterion of P < 0.1 in the univariate conditional
logistic regression models were subjected to multivariate
conditional logistic regression analysis. A value of P <0 . 0 5
was considered statistically significant in the multivariate
analysis. Statistical analyses were performed by SAS soft-
ware version 9.1 (SAS Institute Inc., Cary, North Carolina)
for data analyses with two-sided probability value.
Results
Baseline characteristics of the study population
Medical data for 14900 individuals were used in our
analysis, including 3725 previously diagnosed with
cholelithiasis (symptomatic cholelithiasis; case group)
and 11175 with no history of cholelithiasis or medically
related procedures (control group). The study was made
up of 6484 males (43.5%) and 8416 females (56.5%), and
participants ranged in age from 20 to 98 years (mean
age = 55.9 ± 15.9 years). It should be noted that because
of the study design (see Methods), the age distributions
are the same in the case and control groups, as are the
mean ages for case and control groups (Table 1).
Risk factors for cholelithiasis
Univariate analysis identified seven medical conditions
as potential risk factors for the development of chole-
lithiasis: obesity, diabetes mellitus, hyperlipidemia, hepa-
titis B infection, hepatitis C infection, and cirrhosis were
identified in both genders. Menopause was identified as
an additional risk factor for cholelithiasis in females (P <
0.001) (Table 2).
Multivariate conditional logistic regression analysis
was used to determine the independence of risk factors
associated with cholelithiasis. Individuals with the fol-
lowing conditions were more likely to have cholelithiasis
than individuals without the condition: obesity (OR =
1.89 with 95% CI of 1.18-3.04); hyperlipidemia (OR =
1.54 with 95% CI of 1.38-1.72); hepatitis B or C infec-
tions (OR = 2.00 with 95% CI of 1.55-2.60 for hepatitis
B; OR = 2.78 with 95% CI of 2.01-3.84 for hepatitis C);
and cirrhosis (OR = 2.47 with 95% CI of 1.72-3.53). In
addition to these risk factors menopause was identified
in the multivariate analysis as a risk factor for chole-
lithiasis in females (OR = 1.61 with 95% CI of 1.38-
1.89). Diabetes mellitus was not identified as a confer-
ring a significant risk for the development of cholelithia-
sis (Table 3).
Discussion and Conclusions
Cholelithiasis in some form-silent gallstones [19], simple
biliary colic pain, acute cholecystitis sepsis, and, infre-
quently, gallstone ileus [20,21]–has accounted for an
Table 2 Summary for the risk factors of cholelithiasis in univariate conditional logistic regression models
Cholelithiasis
Yes
(n = 3725)
No
(n = 11175)
OR 95% CI P value
Obesity 30 (0.81%) 42 (0.38%) 2.16 1.35 - 3.45 0.001*
Diabetes mellitus 513 (13.77%) 1 236 (11.06%) 1.31 1.17 - 1.47 < 0.001*
Hyperlipidemia 662 (17.77%) 1 349 (12.07%) 1.62 1.46 - 1.8 < 0.001*
Chronic kidney disease 57 (1.53%) 136 (1.22%) 1.27 0.92 - 1.73 0.142
Hepatitis B 108 (2.90%) 143 (1.28%) 2.31 1.79 - 2.97 < 0.001*
Hepatitis C 82 (2.20%) 76 (0.68%) 3.3 2.41 - 4.52 < 0.001*
Cirrhosis 65 (1.74%) 65 (0.58%) 3.05 2.16 - 4.32 < 0.001*
Menopause
# 304 (14.45%) 612 (6.70%) 1.65 1.41 - 1.93 < 0.001*
OR: odds ratio; CI: confidence interval.
#Calculated in female subjects (2104 cases and 6312 controls). *Indicating the corresponding variable that had significant
impact on the occurrence of cholelithiasis. Each OR was calculated by univariate conditional logistic regression
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ing healthcare concern in Taiwan [7,8]. Although the
growing prevalence of cholelithiasis has been linked
informally to an increase in influence of the Western
diet, obesity, and sedentary lifestyle, differences in gall-
stone composition indicate there may be differences as
well in the etiology of cholelithiasis in Taiwan compared
to the West. Despite differences in the predominate
type of gallstone in Asian versus Western populations,
we identified no unique risk factors among the popula-
tion of Taiwan. Using multivariate conditional logistic
regression analysis, we identified the following as inde-
pendent risk factors for cholelithiasis (in descending
order of contribution): Among all patients - hepatitis C
(OR = 2.78), cirrhosis (OR = 2.47), hepatitis B (OR =
2.00), obesity (OR = 1.89), and hyperlipidemia (OR =
1.54); Among women - hepatitis C (OR = 3.05), cirrho-
sis (OR = 1.92), obesity (OR = 1.91), menopause (OR =
1.61), hepatitis B (OR = 1.54), and hyperlipidemia (OR =
1.49).
The prevalence of cholelithiasis has been estimated at
approximately 4.3 to 14.4%, with a calculated annual
incidence of 2.6~3.56% [8,14,15,22,23]. Around one-
third of individuals for whom an initial diagnosis of gall-
stones is asymptomatic or noncritical will undergo a
subsequent cholecystectomy for recurrent symptoms or
complications [24,25]. Prophylactic surgical treatment
for complicated cholecystitis has also been discussed for
high risk sub-group individuals [13,19,25]. Identifying
the major risk factors for cholelithiasis is an important
step in preventing the formation of gallstones and redu-
cing cholelithiasis-related illness.
The majority of studies into risk factors for chole-
lithiasis have been based on data from Western coun-
tries [25,26]. In the Asia-pacific area, especially in
Taiwan, research into the incidence, prevalence, and risk
factors associated cholelithiasis are usually conducted in
a single hospitals, limited areas, or a limited sub-group
of individuals [8,14-16]. The introduction of the
National Health Insurance database offered a means to
analyze data from the general population of Taiwan.
In selecting the medical conditions for analysis, we
were constrained by the level of specificity within the
database (e.g., data for hyperlipidemia were available,
but data for HDL and LDL levels were not provided).
We were particularly interested in evaluating medical
conditions with particular relevance to the population of
Taiwan. Hepatitis B and C were of interest, because
their prevalence is much higher in Taiwan than in wes-
tern countries. Conversely, blood cholesterol level was
not evaluated, because the majority of cases of chole-
lithiasis in Taiwan do not involve cholesterol stones (see
below).
Gallstones are generally classified as belonging to one
of two types: cholesterol stones, and pigment stones [1].
Pigment stones can be further subdivided into high-resi-
due pigment, low-residue pigment, and muddy pigment
stones [9]. Cholesterol stones are formed by the precipi-
tation of cholesterol as solid crystals from supersatu-
rated bile and reflect high levels of hepatic cholesterol
secretion. Pigment stones, which are more predominant
in the Asian population [9-11], are composed primarily
of bilirubinate salts and oxidized tetrapyrrolic derivatives
formed by polymerization of unconjugated bilirubin
[27]. This type of gallstone is linked to hemolysis, bac-
terial infection, or liver disease, rather than hormonal
factors [1,12]. Others also report an association between
pigment gallstones and advancing age and possibly alco-
h o l i s m[ 2 8 ] .W ew e r eu n a b l et o directly assess the dis-
tribution of gallstone types in this study, because no
clinical test reports regarding signs of hyperhemolysis
(lower hemoglobin content) were available in the data-
base. Chronic liver disease is a well-recognized risk fac-
tor for cholelithiasis [4,23]. Fatty liver [12], hepatitis B
[16,22], hepatitis C [6,29], elevated ALT levels [15], and
cirrhosis [22,30,31] have all been found to be related to
cholelithiasis in different small studies. In Taiwan there
is known to be a higher prevalence of viral hepatitis
than in other regions [32]. Our study confirms that
hepatitis B, hepatitis C, and cirrhosis contribute a signif-
icant risk for cholelithiasis. Additional studies to under-
stand the mechanistic relationship between
cholelithiasis, virus hepatitis, alcohol-related cirrhosis,
viral hepatitis cirrhosis, as well as non-alcoholic fatty
liver disease are needed [33].
All of the constituents of metabolic syndrome, with
the exception of hypertension, have been reported as
independent risk factors for cholelithiasis, including low
serum levels of high density lipoprotein [13,34,35], dia-
betes and glucose intolerance [12,13,16,22,29,34], high
Table 3 Summary for the risk factors of cholelithiasis in
Multivariate conditional logistic regression models for all
subject and females
For all subjects
(Case, n = 3725;
Control, n = 11175)
For female subjects
(Case, n = 2104;
Control, n = 6312)
OR OR
(95% CI)
P value OR OR
(95% CI)
P value
Obesity 1.89 1.18-3.04 0.008* 1.91 1.07-3.41 0.030*
Diabetes mellitus 1.13 1.00-1.27 0.054 1.09 0.92-1.28 0.323
Hyperlipidemia 1.54 1.38-1.72 < 0.001* 1.49 1.29-1.72 < 0.001*
Hepatitis B 2.00 1.55-2.60 < 0.001* 1.54 1.04-2.28 < 0.001*
Hepatitis C 2.78 2.01-3.84 < 0.001* 3.05 2.01-4.62 < 0.001*
Cirrhosis 2.47 1.72-3.53 < 0.001* 1.92 1.03-3.58 < 0.001*
Menopause
# — 1.61 1.38-1.89 < 0.001*
OR: odds ratio; CI: confidence interval.
#Calculated in female subjects (2104
cases and 6312 controls). * Indicated the corresponding variable had
significant impact on the occurrence of cholelithiasis.
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[15], and obesity [15,34,35,38]. In the present study, we
identified obesity and hyperlipidemia as strong risk fac-
tors in the general population of Taiwan. Overall, these
findings point to a likely benefit of life style and dietary
modification as effective measures for the prevention of
cholelithiasis [39]. In addition, they support previous
observations indicating that medications used to treat
dyslipidemia may be of value in the prevention and
treatment of cholelithiasis [31,40].
We found a strong association between diabetes and
cholelithiasis in univariate analysis, but did not identify
diabetes as a significant independent risk factor in mul-
tivariate analysis. There remains some controversy in
the literature regarding type 2 diabetes as an indepen-
dent risk factor for cholelithiasis. Previous community-
based studies in healthy adults in Taiwan have found
diabetes mellitus to be highly associated with the preva-
lence of gallstone disease [12,16]. In addition, Chen et
al. [12] found diabetes to be an independent risk factor
for gallstone disease in women, but not in men. Type 2
diabetes has also been reported as an independent risk
factor for gallstone disease in women but not men in
Western studies [41]. In contrast, other investigators
have found no independent link between type 2 diabetes
and the development of gallstones. Pacchioni et al. [42]
observed that obesity and type 2 diabetes were both
more frequent in patients with gallstones than in those
without gallstones, and suggested that age and obesity
are the main risk factors for gallstones, with type 2 dia-
betes playing a lesser role in the development of gall-
stones. Shaffer et al. [4] concluded that while diabetes
mellitus may be linked to gallstone formation, the rela-
tionship is influenced by co-factors such as age, body
mass index, and a family history of gallstone disease.
Our results support the idea that type 2 diabetes acts in
concert with diet, BMI, and other factors to increase the
risk of cholelithiasis.
There remains some controversy about gender as a
risk factor for cholelithiasis. While the majority of stu-
dies conducted in the West have concluded that females
are more likely than males to develop cholelithiasis
[4,38,43], several studies with among Asian patients
have failed to identify a gender-related difference
[12,14,29]. In fact Liu et al. [16] found a higher inci-
dence of cholelithiasis in males than in females below
50 years of age, but a higher incidence in females than
in males in age groups above 50 years. In the present
study, we did not assess the effect of gender, itself, but
did assess the relative risks for pre- and post-menopau-
sal women. Our analysis indicated that menopause is a
risk factor for cholelithiasis in females. In the vacillating
era of hormone replacement, the effect of estrogen
might be an uncertain factor for which we were unable
to control [44].
The relationship between chronic kidney disease and
cholelithiasis continues to be investigated [30,45].
Chronic kidney disease may alter plasma concentrations
of electrolytes, including calcium. Like bilirubin and
cholesterol, calcium is a major component of gallstones.
In the present study we have defined chronic kidney dis-
ease as a condition meeting the criteria for ICD-9-CM
585, 586, 588.8, or 588.9. In this context, we found no
significant influence of chronic kidney disease on gall-
stone formation. However, since pigment gallstones pre-
dominate in Asian populations, further studies into the
relationship between the renal function, parathyroid
hormone, and calcium levels will be of interest.
A significant limitation of this study is that our
research database did not reveal the criteria on which
the diagnoses of cholelithiasis were based. Thus, it is
more appropriate to describe these individuals as having
symptomatic cholelithiasis as defined within the ICD-9-
CM 574 guidelines, i.e., calculus of the gallbladder with-
out mention of cholecystitis. Similarly, individuals in the
control group had no history of cholelithiasis, but we
are unable to rule out the possibility of asymptomatic
cholelithiasis in some individuals. In addition, because
of the inherent limitations of insurance data, some life-
style risks, such as the use of ground-surface water, can-
not be evaluated [46]. We were also unable to analyze
the link between cholelithiasis and family history or par-
ity in our population. Thus, further prospective studies
will be required to better understand the relationship of
these factors to cholelithiasis in Taiwan.
This study was designed to identify medical risk fac-
tors for cholelithiasis in the general population of Tai-
wan. The goal was to determine if the risk profile in the
general population differed from those reported pre-
viously from studies with specific segments of the Tai-
wanese population, as well as from known risk factors
in the West. Although no unique risk factors were iden-
tified among the population of Taiwan, this study con-
firms hepatitis B as a risk factor in the Taiwanese
population, which is an important finding in view of the
higher prevalence of hepatitis in Taiwan. The chole-
lithiasis-risk profile as represented in this survey of a
representative population of Taiwan is similar overall to
the profile that has emerged from the study of specific
segments of the population, identifying obesity, hyperli-
pidemia, hepatitis B infection, hepatitis C infection and
cirrhosis as risk factors for cholelithiasis in men and
women, and menopause as an additional risk factor in
females. Our study indicates that diabetes mellitus may
not be an independent risk factor for cholelithiasis, and
this relationship should be re-examined.
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